Matrix metalloproteinase-2 (MMP-2) and MMP-9 cleavage by SCUBE3 releases fragments, which can bind to transforming growth factor-b (TGF-b) type II receptors, thereby activating the TGF-b signal transduction and promoting tumor development (53). Here, MMP9 is linked to neoplasm.